ABO blood type compatibility did not play a role in corneal transplant failure stemming from graft rejection in low-risk cases. Investigators aimed to determine whether ABO compatibility affected ...

Transplantation of hearts from ABO-incompatible donors is contraindicated because of the risk of hyperacute rejection mediated by preformed antibodies in the recipient to blood-group antigens of the ...

There is no consensus on the best method of managing ABO-incompatible BMT. 18 The most commonly used strategy is red cell depletion. Herein, we report on the safety of recipient plasma exchange ...

Toronto, ON - Researchers at Toronto's Hospital for Sick Children report that their recent switch to using the first available size-appropriate heart for neonates and infants regardless of ABO blood ...

Use of ABO-incompatible renal transplants from living donors has proven a viable and practical transplantation strategy. The protocols devised through the Johns Hopkins Incompatible Kidney Transplant ...

Toronto, ON - Hearts from ABO-incompatible donors can be safely transplanted into infants before they develop the natural antibodies that trigger hyperacute rejection, a new report suggests. In the ...

Kidney diseases are increasingly being recognised as a global health challenge, affecting millions of people and placing a substantial burden on families, healthcare systems, and economies. Often ...

A pediatric heart transplant procedure pioneered by Canadian doctors--once deemed impossible--has been shown to be at least as effective as the traditional approach, according to newly published ...

ABO-incompatible heart transplantation (heart transplantation among noncompatible blood groups) can be safely performed in infants a year old or younger, researchers report. ABO-incompatible heart ...

Dorry Segev, MD MARCO ISLAND, Fla.—A brief escalation in immunosuppression without long-term B-cell depletion may provide excellent long-term patient and graft survival after ABO-incompatible (ABOi) ...

Daratumumab, a human IgG1κ monoclonal antibody targeting CD38, is used to treat multiple myeloma. We describe successful treatment with daratumumab in a case of treatment-refractory pure red-cell ...

In a significant advancement for specialized healthcare in Manipur, BABINA Hospital has successfully carried out its first ABO-incompatible kidney transplant, marking an important milestone in the ...